Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$9.01M Sell
55,525
-8,835
-14% -$1.39M 1.09% 21
2015
Q3
$8.9M Buy
64,360
+16,141
+33% +$2.54M 1.02% 28
2015
Q2
$7.4M Sell
48,219
-2,100
-4% -$336K 0.32% 94
2015
Q1
$8.04M Sell
50,319
-2,130
-4% -$335K 0.33% 102
2014
Q4
$8.36M Sell
52,449
-3,517
-6% -$548K 0.34% 101
2014
Q3
$7.86M Sell
55,966
-10,543
-16% -$1.38M 0.35% 96
2014
Q2
$7.87M Buy
66,509
+16,769
+34% +$1.94M 0.33% 104
2014
Q1
$6.13M Buy
49,740
+215
+0.4% +$26.1K 0.28% 111
2013
Q4
$5.65M Sell
49,525
-2,176
-4% -$248K 0.27% 118
2013
Q3
$5.79M Buy
51,701
+2,915
+6% +$316K 0.3% 110
2013
Q2
$4.81M Buy
+48,786
New +$5.06M 0.28% 116

Other funds holding AMGN

Stratton Management's AMGN Position: Q4 2015 in Review

Stratton Management reduced its Amgen (AMGN) stake by 14% in Q4 2015, selling an estimated $1.39M and leaving 55,525 shares worth $9.01M. The position accounts for 1.09% of the portfolio, ranked #21.

Stratton Management first reported a position in AMGN in Q2 2013 and has held it in 11 quarters since. 1,454 funds tracked by Wall St. Rank hold AMGN as of Q4 2015.

  • Stratton Management held 55,525 shares of Amgen worth $9.01M as of Q4 2015.
  • Stratton Management sold 8,835 Amgen shares in Q4 2015, an estimated $1.39M.
  • Amgen made up 1.09% of Stratton Management's portfolio in Q4 2015, its #21 holding.
  • Stratton Management first reported a position in Amgen in Q2 2013 and has held it in 11 quarters since.
  • 1,454 funds tracked by Wall St. Rank held Amgen as of Q4 2015.

Based on Stratton Management's 13F filing for Q4 2015, filed 11 Feb 2016.